financetom
Business
financetom
/
Business
/
Citi reaffirms focus on regulatory compliance ahead of key unit's investor day
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citi reaffirms focus on regulatory compliance ahead of key unit's investor day
Jun 18, 2024 6:24 AM

June 18 (Reuters) - Citigroup ( C/PN ) said on Tuesday it

will redouble its efforts to automate certain processes and data

related to regulatory reporting, and is committed to investing

in its risk and control environment in the near term.

The lender has been facing some regulatory challenges tied

to its so-called living will that details how the firm would be

unwound in the event of bankruptcy.

The board of the Federal Deposit Insurance Corp, a top

banking regulator, plans to vote on Thursday to downgrade its

rating on Citi's data-management systems to a "deficiency" from

a "shortcoming", Reuters reported on Monday.

Citi CEO Jane Fraser will give opening remarks in an

investor day on Tuesday, highlighting the strategy for its

services business, which helps to manage payments and liquidity

for multinational corporations.

She will be followed by Chief Financial Officer Mark Mason

and Shahmir Khaliq, who leads services.

The presentations will allow investors "to dive deeper into

a business that is at the heart of our strategy and unmatched

global network," Fraser said in a statement before the event.

Services is Citigroup's ( C/PN ) most profitable division and is

central to Fraser's turnaround strategy. The business generates

about 20% of Citi's revenue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know
Oct 30, 2025
Intensity Therapeutics Inc. ( INTS ) shares are trending on Friday. Check out the current price of INTS stock here.  Shares of the biotechnology company rallied 394.9% in Thursday's regular session after Phase 1/2 clinical trial results for INT230‑6, an intratumoral therapy combining cisplatin and vinblastine sulfate, were published in eBioMedicine, but the gains tapered in after-hours trading to $0.90,...
Corbus Pharmaceuticals Announces Pricing of Public Offering
Corbus Pharmaceuticals Announces Pricing of Public Offering
Oct 30, 2025
NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. ( CRBP ) (“Corbus” or the “Company”), an oncology and obesity company, today announced the pricing of an underwritten public offering of 4,744,231 shares of its common stock at a public offering price of $13.00 per share, and, in lieu of common stock to certain investors, pre-funded warrants...
Form 8.3 - Offeree = Big Yellow Group plc
Form 8.3 - Offeree = Big Yellow Group plc
Oct 31, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Long Pond Capital, LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Aalberts N.V.: Aalberts completes acquisition of Grand Venture Technology Limited
Aalberts N.V.: Aalberts completes acquisition of Grand Venture Technology Limited
Oct 30, 2025
Utrecht, 31 October 2025 Aalberts ( AALBF ) completes acquisition of Grand Venture Technology Limited Aalberts ( AALBF ) announces successful completion of the acquisition of Grand Venture Technology Limited (GVT). With its head office in Singapore, GVT operates six facilities across Singapore, Malaysia and China, generating an annual revenue of SGD 160 million in 2024 and an adjusted EBITDA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved